[1]
“Molecular Docking and QSAR studies for Modeling Antifungal Activity of Triazine Analogues against Therapeutic Target NMT of Candida albicans”, Int. J. Pharm. Sci. Drug Res., vol. 13, no. 2, pp. 140–146, Mar. 2021, doi: 10.25004/IJPSDR.2021.130204.